EN DE
STOCK COMPARISON

Akzo Nobel vs Linde plc Ordinary Shares: Fair Value & Quality

Both stocks run through our valuation models. Here is how Akzo Nobel (AKZA) and Linde plc Ordinary Shares (LIN) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees Akzo Nobel as the less overvalued of the two: Akzo Nobel trades at €63.56 versus a fair value of €41.45 (-35%), while Linde plc Ordinary Shares trades at $490 versus $226 (-54%).
Akzo Nobel
AKZA.AS · EUR · Materials
-35%
upside to fair value
overvalued
Price€63.56
Fair Value€41.45
Quality57/100
Linde plc Ordinary Shares
LIN · USD · Materials
-54%
upside to fair value
overvalued
Price$490
Fair Value$226
Quality69/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Akzo NobelLinde plc Ordinary Shares
Valuation
15.9×P/E (TTM)34.1×
1.14×P/S (TTM)6.95×
2.43×P/B6.30×
12.3×EV/EBITDA18.9×
2.39×PEG2.18×
3.5%Dividend yield1.2%
€1.98Dividend per share$6.10
Profitability
6%Net margin20%
8%Operating margin28%
13%Return on equity18%
3%Return on assets7%
Growth
-9%Revenue growth (YoY)8%
-2.2%Avg. growth/yr (3Y)0.6%
3.6%Avg. growth/yr (5Y)4.5%
Balance & size
0.75×Debt / equity0.54×
$11BMarket cap$241B
mixedGrowth qualityhealthy

Linde plc Ordinary Shares leads: 5 to 9 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Akzo Nobelof which business quality 56 · market factors 58 Linde plc Ordinary Sharesof which business quality 66 · market factors 62
ProfitabilityMargins and returns on capital today
46
51
Quality GrowthAre margins and returns improving?
42
51
CashflowEarnings quality: real cash, not paper profit
48
64
Fin. StrengthBalance sheet, leverage, solvency risk
44
69
InvestmentDisciplined investing over empire-building
94
70
Low VolatilityCalm price path (market factor)
49
87
MomentumPrice trend over the last 3–12 months (market factor)
59
50
52W MomentumDistance to the 52-week high (market factor)
68
53
Net IssuanceBuybacks instead of dilution
83
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Akzo Nobel

DCF Models€41.81
Earnings-Based€23.75
Dividend Discount€20.21
Multiples€66.75
Asset-Based€18.22
Growth DCF€38.99
Economic Profit€23.95
Growth Earnings€56.20

21 of 24 models see the stock below the current price.

Linde plc Ordinary Shares

DCF Models$225
Earnings-Based$132
Dividend Discount$116
Multiples$273
Asset-Based$55.42
Growth DCF$186
Economic Profit$156
Growth Earnings$225

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Akzo Nobel
Bear €25.59Fair Value €41.45Bull €66.11
€63.56 = current price (white tick)
Linde plc Ordinary Shares
Bear $123Fair Value $226Bull $296
$490 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Akzo Nobel · Materials

Quality score57 · Top 25%
Fair value upside-35% · below median

Linde plc Ordinary Shares · Materials

Quality score69 · Top 25%
Fair value upside-54% · below median

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees Akzo Nobel as the less overvalued of the two: Akzo Nobel trades at €63.56 versus a fair value of €41.45 (-35%), while Linde plc Ordinary Shares trades at $490 versus $226 (-54%).

Linde plc Ordinary Shares has the higher quality score (69/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.